drugset / Trial / NCT04276558
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
RandomizedSequentialTriple-blindTreatment
Summary
A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559 in treatment of Neurotrophic Keratitis in Adult Patient in Europe and United States of America.
Timeline
- Start
- 2020-10-13
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Udonitrectag | Small molecule | 0.5 ug | Topical |
| Subject | Udonitrectag | Small molecule | 2.5 ug | Topical |
| Subject | Udonitrectag | Small molecule | 5 ug | Topical |